Skip to main content
Barbara Davis, DO, Internal Medicine, Mission Viejo, CA, Providence Mission Hospital Mission Viejo

BarbaraJeanDavisDO

Internal Medicine Mission Viejo, CA

Hospice & Palliative Medicine, Hospital Medicine/Hospitalist

Monarch

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Davis' full profile

Already have an account?

Summary

  • Dr. Barbara Davis is an internist in Mission Viejo, CA and is affiliated with multiple hospitals in the area, including Mission Hospital Mission Viejo, Saddleback Medical Center, and Children's Hospital of Orange County. She received her medical degree from Kansas City University of Medicine and Biosciences and has been in practice 13 years. She specializes in hospice & palliative medicine and hospital medicine/hospitalist.

Education & Training

  • University of Arizona College of Medicine-Phoenix
    University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2004 - 2007
  • Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
    Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State License 2007 - 2026
  • AZ State Medical License
    AZ State License 2004 - 2006
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hospice and Palliative Medicine

Publications & Presentations

PubMed

Press Mentions

  • COVID‐19 Pandemic and Diabetes Care
    COVID‐19 Pandemic and Diabetes CareApril 25th, 2022
  • Primary Care and Diabetes Technologies and Treatments
    Primary Care and Diabetes Technologies and TreatmentsApril 25th, 2022
  • RX-5902, a Novel Β-catenin Modulator, Potentiates the Efficacy of Immune Checkpoint Inhibitors in Preclinical Models of Triple-Negative Breast Cancer
    RX-5902, a Novel Β-catenin Modulator, Potentiates the Efficacy of Immune Checkpoint Inhibitors in Preclinical Models of Triple-Negative Breast CancerNovember 4th, 2020

Grant Support

  • Mechanistic Studies Of Female Reproductive ToxicantsNational Institute Of Environmental Health Sciences2003
  • Mechanistic Studies Of Female Reproductive Toxicants AndNational Institute Of Environmental Health Sciences2001–2002
  • Mechanistic Studies Of Female Reproductive Toxicants And CarcinogensNational Institute Of Environmental Health Sciences1999–2000
  • Pathogenesis Of Ovarian ToxicantsNational Institute Of Environmental Health Sciences1994–1996
  • Mechanistic Studies Of Ovarian ToxicityNational Institute Of Environmental Health Sciences1994–1995
  • Pathogenesis Studies Of Ovarian ToxicantsNational Institute Of Environmental Health Sciences1992–1993

Professional Memberships

Hospital Affiliations